Stay updated on IRX-2 Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.

Latest updates to the IRX-2 Combo in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior v3.4.1 revision banner.SummaryDifference0.4%

- Check20 days agoChange DetectedThe page now includes notices about government funding and NIH operating status updates, and the site version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated multiple UI labels to reflect the new revision (v3.4.0) and capitalization changes, including Last Update and No FEAR Act Data lines.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4; this appears to be a minor site version update with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedConsolidated the Locations section to display Arizona, California, and Texas (Revision: v3.3.3). Removed the separate Arizona Locations, California Locations, and Texas Locations entries, and removed the HHS Vulnerability Disclosure link.SummaryDifference0.4%

- Check92 days agoChange DetectedA revision label in the page footer updated from v3.2.0 to v3.3.2; this is a minor UI update that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.